Target intelligence / Profile preview

Cardiovascular System Homeostasis (None)

Target
None
Molecular classification
Other (encompasses multiple classes such as receptors [e.g., angiotensin II receptor], enzymes [e.g., ACE], ion channels, transporters involved in cardiovascular regulation)
01

Overview

Cardiovascular system homeostasis encompasses the dynamic balance maintained by neural reflexes, endocrine signals, local autoregulatory mechanisms, cellular interactions within the heart and vessels ensuring adequate tissue perfusion under varying physiological conditions. Key neural components include baroreceptors sensing blood pressure changes and chemoreceptors monitoring oxygen/carbon dioxide/pH levels that relay information centrally to adjust cardiac output and vascular resistance accordingly. Endocrine factors such as epinephrine/norepinephrine released during stress increase heart rate/contractility while hormones like angiotensin II regulate fluid balance through vasoconstriction/sodium retention. At the cellular level within the heart are cardiomyocytes responsible for pumping action whose gene expression programs adapt during stress states. Immune cells resident in cardiac tissues contribute both to normal physiology—such as electrical conduction—and pathological remodeling after injury. The renin–angiotensin–aldosterone system plays a pivotal role in long-term blood pressure regulation with angiotensin II acting mainly through its G protein-coupled AT1 receptor inducing hypertrophic responses when overstimulated. Overall this integrated network ensures stable internal environment despite external fluctuations—termed “homeostasis”—critical for survival. Disruption leads to diseases including hypertension, ischemia-related damage, arrhythmias,and chronic heart failure.

Other names
Cardiovascular homeostatic regulationCirculatory system homeostasisVascular homeostasis
02

Mechanism of action

Mechanisms by which drugs modulate cardiovascular homeostatic pathways include: Inhibition/blockade of angiotensin II type 1 receptor reducing vasoconstriction and sodium retention; Beta-adrenoceptor blockade reducing heart rate/cardiac output via sympathetic inhibition; Enhancement or mimicry of nitric oxide signaling causing vasodilation. These drugs act on specific receptors or enzymes that regulate cardiovascular function but do not target "cardiovascular system homeostasis" per se.

03

Biological functions

Regulation of blood pressureRegulation of cardiac outputMaintenance of vascular tone via vasodilation/vasoconstrictionOxygen delivery to tissuesRemoval of metabolic waste products like CO2Neural reflex control (baroreceptor and chemoreceptor reflexes)Endocrine regulation via hormones such as epinephrine/norepinephrine, renin–angiotensin–aldosterone system componentsAutoregulation at local tissue level through chemical signals and myogenic responses
04

Disease associations

Cardiovascular disease including hypertension, heart failureCirculatory shock states such as hypovolemic shockVascular aging and calcification contributing to vascular disease
05

Safety considerations

Risk of hypotension from excessive vasodilation or over-inhibitionElectrolyte imbalances due to diuretics affecting volume statusArrhythmias from autonomic nervous system modulation disturbances
06

Interacting drugs

Angiotensin-converting enzyme inhibitors (ACE inhibitors)

3 more in the full profile.

07

Biomarkers

Blood pressure measurements for systemic arterial pressure control assessmentPlasma levels of natriuretic peptides (e.g., BNP/Nppa), markers for cardiac stress/homeostatic imbalanceRenin activity/angiotensin II levels reflecting RAS activationOxygen saturation/pH reflecting respiratory-cardiovascular integration

Beyond the preview

Go deeper on Cardiovascular System Homeostasis (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cardiovascular System Homeostasis (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call